Millennium Management’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.56M | Buy |
350,535
+296,552
| +549% | +$3.01M | ﹤0.01% | 2299 |
|
|
2025
Q1 | $301K | Buy |
53,983
+26,349
| +95% | +$147K | ﹤0.01% | 3485 |
|
|
2024
Q4 | $223K | Sell |
27,634
-265,889
| -91% | -$2.15M | ﹤0.01% | 3628 |
|
|
2024
Q3 | $3.01M | Sell |
293,523
-488,776
| -62% | -$5.01M | ﹤0.01% | 2301 |
|
|
2024
Q2 | $5.53M | Buy |
782,299
+585,447
| +297% | +$4.14M | ﹤0.01% | 1864 |
|
|
2024
Q1 | $2.71M | Buy |
+196,852
| New | +$2.71M | ﹤0.01% | 2403 |
|
|
2023
Q4 | – | Sell |
-1,163,760
| Closed | -$7.04M | – | 4399 |
|
|
2023
Q3 | $7.04M | Buy |
1,163,760
+7,650
| +0.7% | +$46.3K | ﹤0.01% | 1663 |
|
|
2023
Q2 | $8.97M | Sell |
1,156,110
-1,111,532
| -49% | -$8.63M | ﹤0.01% | 1543 |
|
|
2023
Q1 | $12.9M | Buy |
2,267,642
+383,664
| +20% | +$2.19M | 0.01% | 1236 |
|
|
2022
Q4 | $11.1M | Buy |
1,883,978
+355,370
| +23% | +$2.09M | 0.01% | 1479 |
|
|
2022
Q3 | $4.89M | Buy |
1,528,608
+86,631
| +6% | +$277K | ﹤0.01% | 2204 |
|
|
2022
Q2 | $6.46M | Buy |
1,441,977
+1,064,486
| +282% | +$4.77M | ﹤0.01% | 1925 |
|
|
2022
Q1 | $2.02M | Buy |
+377,491
| New | +$2.02M | ﹤0.01% | 3050 |
|
|
2021
Q3 | – | Sell |
-231,853
| Closed | -$4.1M | – | 5355 |
|
|
2021
Q2 | $4.1M | Buy |
231,853
+108,396
| +88% | +$1.92M | ﹤0.01% | 2358 |
|
|
2021
Q1 | $3.03M | Buy |
123,457
+21,595
| +21% | +$529K | ﹤0.01% | 2512 |
|
|
2020
Q4 | $3.45M | Buy |
101,862
+77,372
| +316% | +$2.62M | ﹤0.01% | 2168 |
|
|
2020
Q3 | $612 | Buy |
+24,490
| New | +$612 | ﹤0.01% | 2754 |
|